tiprankstipranks
Trending News
More News >
Enzolytics Inc. (ENZC)
OTHER OTC:ENZC
US Market

Enzolytics (ENZC) Price & Analysis

Compare
465 Followers

ENZC Stock Chart & Stats


---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.05%99.95%
Insiders
Mutual Funds
0.05% Other Institutional Investors
99.95% Public Companies and
Individual Investors

ENZC FAQ

What was Enzolytics Inc.’s price range in the past 12 months?
Enzolytics Inc. lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
    What is Enzolytics Inc.’s market cap?
    Enzolytics Inc.’s market cap is $2.56M.
      When is Enzolytics Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Enzolytics Inc.’s earnings last quarter?
      Currently, no data Available
      Is Enzolytics Inc. overvalued?
      According to Wall Street analysts Enzolytics Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Enzolytics Inc. pay dividends?
        Enzolytics Inc. pays a Notavailable dividend of $156.25 which represents an annual dividend yield of N/A. See more information on Enzolytics Inc. dividends here
          What is Enzolytics Inc.’s EPS estimate?
          Enzolytics Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Enzolytics Inc. have?
          Enzolytics Inc. has 3,941,644,000 shares outstanding.
            What happened to Enzolytics Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Enzolytics Inc.?
            Currently, no hedge funds are holding shares in ENZC
            ---

            Company Description

            Enzolytics Inc.

            Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Aptevo Therapeutics
            Enveric Biosciences
            Ensysce Biosciences
            Revelation Biosciences
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis